Lv15
48 积分 2021-08-08 加入
Targeting interleukin-2-inducible T cell kinase ameliorates immune-mediated aplastic anemia
1天前
已完结
Improving the Solubility, Dissolution, and Bioavailability of Ibrutinib by Preparing It in a Coamorphous State With Saccharin
2天前
已完结
Bioavailability enhancement and pharmacokinetic profile of an anticancer drug ibrutinib by self-nanoemulsifying drug delivery system
3天前
已完结
Discovery of Selective Irreversible Inhibitors for Bruton’s Tyrosine Kinase
3天前
已完结
Landscape of In Silico Tools for Modeling Covalent Modification of Proteins: A Review on Computational Covalent Drug Discovery
4天前
已完结
Computational and biophysical methods for the discovery and optimization of covalent drugs
4天前
已完结
Covalent inhibitors: An ambitious approach for the discovery of newer oncotherapeutics
4天前
已完结
Trends in covalent drug discovery: a 2020-23 patent landscape analysis focused on select covalent reacting groups (CRGs) found in fda-approved drugs
4天前
已完结
Use of pharmacokinetic versus pharmacodynamic endpoints to support human dose predictions: implications for rational drug design and early clinical development
7天前
已完结
Comprehensive Characterization of Bruton’s Tyrosine Kinase Inhibitor Specificity, Potency, and Biological Effects: Insights into Covalent and Noncovalent Mechanistic Signatures
10天前
已完结
皖公网安备34019202002308
